Dechra Pharmaceuticals

Pharmaceuticals
DPH.L
GBX 3,264 (1.6)%
Share price
$ 4.4 bn
Market Cap
$ 5.1 bn
Enterprise Value

Carbon footprint

2.4 Ton
GHG emissions per $ 1 mln investment
0.09x the weighted average for S&P 500
FY2021
How is this calculated?
+4.9%
YOY change in GHG emissions
Weaker than the -8.7% weighted average for S&P 500
FY2021 vs. previous year

Primary Climate Goal

This company has not set a company-wide target for an absolute reduction in GHG emissions yet

GHG emissions and Carbon intensity

Dechra Pharmaceuticals's GHG emissions (location-based) (Kt of CO2e)
Dechra Pharmaceuticals's Carbon intensity (Tons per 1 USDm)

Dechra Pharmaceuticals's carbon footprint

Dechra Pharmaceuticals reported Total CO2e Emissions - Location-Based Scope 1 + Scope 2 for the twelve months ending 30 June 2021 at 12 Kt (+0.57/+4.9% y-o-y). At the sime time, carbon intensity declined to 16 t (-1.8 /-10.1% y-o-y).

Dechra Pharmaceuticals's Scope 3 emissions was down at 1.9 Kt (-0.41 /-17.6% y-o-y). The decline accelerated compared to the CAGR of -7.2% since 2Q'19.

The company has not set a company-wide target for an absolute reduction in GHG emissions yet.

Company environmental metrics

Show more...